National STD Curriculum from the University of Washington STD Prevention Training Center. Provides information on different STDs and STIs, which are available for Quick Reference. There is also the option to Self-Study, allowing the user to track progress and receive Continuing Education credit.
From the CDC Morbidity and Mortality Weekly Report, Vol. 70, No. 4, published July 23, 2021.
Summary: "These guidelines for the treatment of persons who have or are at risk for sexually transmitted infections (STIs) were updated by CDC after consultation with professionals knowledgeable in the field of STIs who met in Atlanta, Georgia, June 11–14, 2019. The information in this report updates the 2015 guidelines. These guidelines discuss 1) updated recommendations for treatment of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis; 2) addition of metronidazole to the recommended treatment regimen for pelvic inflammatory disease; 3) alternative treatment options for bacterial vaginosis; 4) management of Mycoplasma genitalium; 5) human papillomavirus vaccine recommendations and counseling messages; 6) expanded risk factors for syphilis testing among pregnant women; 7) one-time testing for hepatitis C infection; 8) evaluation of men who have sex with men after sexual assault; and 9) two-step testing for serologic diagnosis of genital herpes simplex virus. Physicians and other health care providers can use these guidelines to assist in prevention and treatment of STIs."
Download Resource
- STI-Guidelines-2021.pdf (4.24 MB)
CDC framework for assisting clinicians in discussing the sexual health issues of a patient in order to obtain a more complete picture of the patient's overall health. The guide covers the clinical environment, the Five "P"s, and other dialogue with the patient that may arise by the end of the session.
CDC Guidelines, for clinicians, on the use of doxy PEP for the prevention of bacterial STIs. Provides education on prescribing doxy PEP (such as who benefits and for which STIs, potential side effects, etc.), what is still being researched, and a list of additional resources.
Substance Use Warmline
Peer-to-Peer Consultation and Decision Support
10 am – 6 pm EST Monday - Friday
855-300-3595
Free and confidential consultation for clinicians from the Clinician Consultation Center at San Francisco General Hospital focusing on substance use in primary care
Objectives of the Substance Use Warmline:
- Support primary care providers in managing complex patients with addiction, chronic pain, and behavioral health issues
- Improve the safety of medication regimens to decrease the risk of overdose
- Enhance the treatment, care and support for people living with or at risk for HIV
- Discuss useful strategies for clinicians in managing their patients living with substance use, addiction and chronic pain.
Consultation topics include:
- Assessment and treatment of opioid, alcohol, and other substance use disorders
- Approaches to suspected misuse, abuse, or diversion of prescribed opioids
- Methods to simplify opioid-based pain regimens to reduce risk of misuse and toxicity
- Urine toxicology testing- when to use it and what it means
- Use of buprenorphine and the role of methadone maintenance
- Withdrawal management for opioids, alcohol, and other CNS depressants
- Harm reduction strategies and overdose prevention
- Managing substance use in special populations (pregnancy, HIV, hepatitis)
- Productive ways of discussing (known or suspected) addiction with patients.
The CCC’s multi-disciplinary team of expert physicians, clinical pharmacists and nurses provides consultation to help clinicians manage complex patient needs, medication safety, and a rapidly evolving regulatory environment.
Learn more at http://nccc.ucsf.edu/clinician-consultation/substance-use-management
Download Resource
- CCC Substance Use Warmline Flier EST 7.25.16.pdf (112.12 KB)